The review period has been extended by 90 days. The Food and Drug Administration (FDA) has extended the review period for elinzanetant, an investigational hormone-free therapy for the treatment of ...
The New York State Office of the Medicaid Inspector General (“OMIG”) issued a Listserv Notice on June 26, 2025 advising that its Compliance Program Reviews (“CPRs”) beginning after July 1, 2025, will ...
ALEXANDRIA, Va. — The Air Conditioning Contractors of America (ACCA) Educational Institute standards task team has opened an American National Standards Institute (ANSI) public review period for ...
The information provided in response to the FDA’s Complete Response Letter "constituted a major amendment to the NDA" requiring more time for review. The Food and Drug Administration (FDA) has ...
BOSTON, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare ...
Alaska Airlines and Hawaiian Airlines have agreed with the U.S. Department of Justice to extend their proposed merger's review period to Aug. 15 from the initial scheduled date of Aug. 5, the carriers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results